Key facts
- This page summarizes John E. Imhoff's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Aug 2024, 18:13.
John E. Imhoff - 21 Aug 2024 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)
- Reporting relationship
- Director
- Issuer ticker
- GTHP
- Reported as of
- 21 Aug 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Aug 2024, 18:13:03 UTC
- Prior SEC filing
- 01 Aug 2024
- Next SEC filing
- 02 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s John E. Imhoff
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Imhoff filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 22 Aug 2024.
Change
- Previous filing in this sequence was filed on 01 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GTHP
transaction
Common Stock
Other
- Transaction value
- Shares
- +183,008
- Change %
- +3.5%
- Price
- Shares after
- 5,409,231
- Date
- 21 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093.